Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
133.50
0.00 (0.00%)
Aug 19, 2026, 9:29 AM CST

TPEX:3218 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,2744,2044,2284,0823,4942,632
Revenue Growth
0.24%-0.57%3.58%16.83%32.76%28.18%
Gross Profit
2,4872,4832,5332,4482,1401,636
Operating Income
1,3351,3801,3981,3121,081768.54
Net Income
1,1451,0431,0651,045850.53595.43
Earnings Per Share
13.4612.2612.5312.3110.027.02
EPS Growth
28.89%-2.15%1.79%22.85%42.76%23.22%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Medical Operations Department
3,2593,4413,4722,7512,248
Optical Operation Department
1,093995.97880.79742.82619
Adjustment and Elimination
-147.8-208.48-270.87--235.27
Total
4,2044,2284,0823,4942,632

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0292,1031,9171,6411,2801,040
Total Debt
1,5081,0631,054778.26783.65767.53
Net Cash (Debt)
-478.921,040863.2862.65495.99272.47
Net Cash Growth
-20.47%0.07%73.92%82.03%-41.23%
Net Cash Per Share
-5.6312.2310.1610.165.853.21

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,7781,6661,6721,5541,268911.77
Capital Expenditures
-470.58-562.66-434.65-472.53-489.7-324.44
Free Cash Flow
1,3071,1041,2371,081778.47587.33
Free Cash Flow Growth
5.03%-10.80%14.46%38.87%32.55%10.41%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.19%59.05%59.91%59.98%61.24%62.18%
Operating Margin
31.24%32.83%33.06%32.14%30.94%29.20%
Pretax Margin
33.15%32.01%31.17%32.30%31.26%29.00%
Profit Margin
26.78%24.80%25.18%25.60%24.34%22.62%
FCF Margin
30.58%26.25%29.27%26.48%22.28%22.32%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
7.7507.7507.5007.0005.6604.492
Dividend Per Share Growth
3.33%3.33%7.14%23.67%26.00%19.05%
Dividend Yield
5.74%5.62%4.11%2.84%2.30%2.06%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
9.9211.8615.9222.4628.0536.18
Forward PE
9.6410.6615.2419.4124.6727.75
P/FCF Ratio
8.6511.2113.6921.7130.6536.68
PS Ratio
2.652.944.015.756.838.19